Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters

Canadian Journal of Anaesthesia

Volumn 47, Issue 7, 2000, Pages 680-686

  Chen, Ta Liang ^a   Chen, Tyng Guey ^a   Tai, Yu Ting ^a   Chang, Huai Chia ^a   Chen, Ruei Ming ^a   Lin, Chen Jung ^b   Ueng, Tzuu Huei ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE; BENZO[A]PYRENE; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 3A4; DIMETHYLNITROSAMINE DEMETHYLASE; ENFLURANE; ERYTHROMYCIN; ETHOXYRESORUFIN DEETHYLASE; PENTOXYRESORUFIN; PENTOXYRESORUFIN DEALKYLASE; PROPOFOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ARTICLE; DEFLUORINATION; DEMETHYLATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; HAMSTER; NONHUMAN; PRIORITY JOURNAL;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANILINE COMPOUNDS; ANIMALS; BENZO(A)PYRENE; CRICETINAE; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; DOSE-RESPONSE RELATIONSHIP, DRUG; ENFLURANE; ENZYME INHIBITORS; FLUORINE; HYDROXYLATION; ISOENZYMES; KIDNEY; MALE; MESOCRICETUS; MICROSOMES; NADH DEHYDROGENASE; NADP; PROPOFOL; REPRODUCIBILITY OF RESULTS;

EID: 0033836179     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03019002     Document Type: Article

References (37)

1. Reactions and significance of cytochrome P-450 enzymes
2. Induction and suppression of renal and hepatic cytochrome P450-dependent mono-oxygenases by acute and chronic streptozotocin diabetes in hamsters
3. Induction and inhibition of cytochrome P450-dependent mono-oxygenase in hamster tissues by ethanol
4. Induction of cytochrome P450-dependent monooxygenases in hamster tissues by fasting
5. Renal cytochrome P450
6. The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity
7. Shibboleths and jigsaw puzzles. The fluoride nephrotoxicity enigma (Editorial)
8. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity
9. Propofol: A review of the pharmacology and applications of an intravenous anesthetic agent
10. Pharmacokinetics of propofol during and after long term continuous infusion for maintenance of sedation in ICU patients
11. Effects of i.v. anaesthesia with propofol on drug distribution and metabolism in the dog
12. Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro
13. Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes
14. Human cytochrome P450 monooxygenase system is suppressed by propofol
15. Propofol (Diprivan) pharmacokinetics and metabolism - An overveiw
16. Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery
17. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation
18. Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes
19. Protein measurement with the folin phenol reagent
20. Serum fluoride analysis with the fluoride electrode
21. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction
22. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction
23. Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat
24. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture I. Assay and properties of induced enzyme
25. The carbon monooxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
26. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies
27. Extrahepatic metabolism of drugs in humans
28. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluoriation of sevoflurane, isoflurane, and methoxyflurane
29. 14C-propofol after intravenous dosing to rat, dog and rabbit
30. Pharmacokinetic implications for the clinical use of propofol
31. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurant or enflurane
32. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation
33. First-pass metabolism of cyclosporin by the gut
34. Characterization of cytochrome P450 in extrahepatic tissues
35. Mechanism-based enzyme inactivators
36. Haemodynamic changes during anaesthesia induced and maintained with propofol
37. Cardiovascular effects of propofol and of thiopentone anaesthesia in the sheep